期刊文献+

血浆同型半胱氨酸水平 亚甲基四氢叶酸还原酶基因多态性与强直性脊柱炎的相关性研究 被引量:3

The association analysis of plasma Hcy level and MTHFR gene polymorphism with ankylosing spondylitis
原文传递
导出
摘要 目的探讨血浆同型半胱氨酸(Hcy)水平与强直性脊柱炎(AS)间的联系,分析AS患者MTHFR基因C677T突变的多态性,并探讨MTHFR基因多态性与AS的相关性。方法运用酶联免疫吸附试验(ELISA)测定100例AS患者及60名健康志愿者血浆Hcy浓度,应用多聚酶链反应一限制性内切酶片段长度多态性(PCR-RELP)分析MTHFR基因的多态性。结果AS患者血浆Hcy浓度明显高于对照组,两组间差异有统计学意义(P〈0.01);AS组T/T型、C/T型、C/C型基因频率分布及T、C等位基因频率与对照组比较差异无统计学意义(P〉0.05);AS组。T/T基因型突变的比例与对照组比较差异有统计学意义(P〈0.05);AS组和对照组T/T型的血浆Hcy水平明显高于C/T型和C/C型(P〈0.01)。Logistic回归分析显示高Hcy血症是AS发病的独立危险因素(P〈0.01,OR=4.582,95%CI=1.984~10.585)。结论AS患者血浆Hcy浓度明显高于健康志愿者,高Hcy血症是AS发病的独立危险因素。MTHFR基因T/T型突变是血浆Hcy浓度升高的一个重要影响机制,MTHFR基因T/T型突变可能与AS的发生有相关性。 Objective To investigate the relationship between plasma homocysteine (Hcy) level and ankylosing spondylitis (AS). To analyze the association between the N5, N10 methylenetetrahydrofolate reductase (MTFHR) gene polymorphism and AS. Methods One hundred patients with AS and 60 healthy controls were included in the study. The plasma Hcy level was examined by enzyme-linked immnnoadsnrbent assay and MTHFR gene polymorphism was analyzed by the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). Results Compared with healthy controls, the plasma Hcy level in AS patients was significantly higher than that of the controls (P〈0.01). There was no significant difference in the frequen-cies of MTHFR genotype and alleles between AS and the controls (P〉0.05), But the ratio of T/T genotype mutation was different between AS and the controls (P〈0.05). The plasma Hcy level of T/T genotype was significantly higher than that of C/T or C/C genotype in AS and the controls (P〈0.01). Logisticalregression analysis indicated that Hcy was an independent risk factor for AS (P〈0.01, 0R=4.582, 95%CI= 1.984-10.585). Conclusion The plasma homocysteine level is significantly increased in AS patients. Hyperhomo-cysteinemia is an independent risk factor for AS. MTHFR T/T genotype mutation is an important mechanism of hyperhomocysteinemia and may be related with AS.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第12期822-825,共4页 Chinese Journal of Rheumatology
关键词 脊柱炎 强直性 亚甲基四氢叶酸还原酶 同型半胱氨酸 基因多态性 Spondylitis ankylosing Methylenetetrahydrofolate reductase(NAPDH2) Homocysteine Gene polymorphism
  • 相关文献

参考文献13

  • 1Lazzerini PE, Capecchi PL, Selvi E, et al. Hyperhomoeysteinemia, inflammation and autoimmunity. Autoimmu Rev, 2007, 6: 503- 509.
  • 2Frosst P, Blam HJ, Milos R, et al. A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase. Nat Genet, 1995, 10: 111-113.
  • 3Bonassi S, Hagmar L, Stromberg U, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res, 2000, 60: 1619-1625.
  • 4Pogribny I, Yi P, James SJ. A sensitive new method for rapid detection of abnorm al methylation patterns in global DNA and within CpG islands.Biochem Biophys Res Commun, 1999, 262: 624-628.
  • 5Petri M, Roubenoff R, Dallal GE, et al. Plasma homocysteine as a risk factor for atherothrombotic events in SLE. Lancet, 1996, 348: 1120-1124.
  • 6Aksu K, Turgan N, Oksel F, et al. Hyperhomocysteinaemia in Behcet's disease. J Rheumatology (Oxford), 2001, 40: 687-690.
  • 7Russo C, Morabito F, Luise F. Hyperhomocysteinemia is associated with cognitive impairment in muhiple sclerosis. J Neurol, 2008, 255: 64-69.
  • 8徐晓,周卫华,肖传实,李小峰,王来远.风湿性疾病中高同型半胱氨酸血症的临床研究[J].中华内科杂志,2005,44(2):111-114. 被引量:12
  • 9Schroecksnadel K, Frick B, Wirleitner B, et al. Moderate hyper- homocysteinemia and immune activation. Curr Pharm Biotechmol, 2004, 5: 107-118.
  • 10Brattstrom L, Wilcken DE, Ohrvik J, et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation, 1998, 98: 2520-2526.

二级参考文献12

  • 1Segal R, Baumoehl Y, Elkayam O, et al. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int, 2004,24 :14-19.
  • 2Cheng TY, Chiu CK. Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus.Clin Rheumatol, 2002, 21:251-254.
  • 3Aksu K, Turgan N, Oksel F, et al. Hyperhomocysteinaemia in Behcet's disease. Rheumatology ( Oxford), 2001,40:687-690.
  • 4Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol, 1997,145:408-415.
  • 5Wallberg-Jonsson S, Ohman ML, Dahlqvist SR Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. J Rheumatol, 1997, 24:445-451.
  • 6Ward MM. Premature morbidity from cardiovascular and celebmvascular diseases in women with systemic lupus erythematosus. Arthritis Rheum, 1999, 42:338-346.
  • 7Myllykangas-Luosujarvi R, Aho K, Kautiainen H, et al.Cardiovascular mortality in women with rheumatoid arthritis, J Rheumatol. 1995.22 : 1065-1067.
  • 8Gao XM, Wordsworth P, McMichael A J, et al. Homocysteine modification of HLA antigens and its immunological consequence.Eur J Immunol, 1996,26 : 1443-1450.
  • 9Chilvers MM, Wordsworth P, Stubbs A, et al. TCR usage by homocysteine-specific human CTL J Immunol, 1998, 160 : 3737-3742.
  • 10李群.全国高同型半胱氨酸血症与疾病学术研讨会纪要[J].中华医学杂志,1999,79(6):406-408. 被引量:81

共引文献11

同被引文献61

  • 1余海峰,李春胜,陈军斌,邓晓燕,李招云.慢性肾功能衰竭对血浆同型半胱氨酸水平的影响[J].实用医学杂志,2005,21(3):275-276. 被引量:11
  • 2王文霞,臧卫周,冯艳,徐军.高同型半胱氨酸血症对帕金森病的影响[J].医药论坛杂志,2005,26(9):20-21. 被引量:2
  • 3徐晓龑,王美美,肖传实,李小峰,王来远.类风湿关节炎患者基因组DNA甲基化水平的初步研究[J].中华风湿病学杂志,2006,10(8):462-465. 被引量:12
  • 4杨再兴,梁艳,朱烨,李畅,张玲珍,仲人前.强直性脊柱炎患者血清IL-12水平及临床意义研究[J].中国实验诊断学,2007,11(5):619-621. 被引量:10
  • 5Lazzerini PE, Capecchi PL, Selvi E, et al. Hyperhomocysteinemia: a cardiovascular risk factor in autoimmune diseases? Lupus, 2007,16: 852-862.
  • 6Fijnheer R,Roest M, Haas FJLM,et al. Homocysteine,methylenetetrahydrofolate reductase polymorphism,antiphospholipid antibodies,and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. J Rheumatol, 1998,25:1737-1742.
  • 7Refai TMK,AI-Salem IH,Nkansa-Dwamena D,et al. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients. Clin Rheumatol, 2002,21:457-461.
  • 8Tso TK, Huang WN, Huang HY, et al. Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. Rheumatology, 2006,45:1148-1153.
  • 9Petri M,Roubenoff R,Dallal GE,et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet, 1996,348: 1120-1124.
  • 10Feldt JMV,Scalzi LV,Cucchiara AJ,et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum,2006,54(7) :2220-2227.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部